Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome.

Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Abstract Text:

    michael friedmanMichael Friedman,berk gurpinarBerk Gurpinar,hsin-ching linHsin-Ching Lin,paul schalchPaul Schalch,ninos j josephNinos J Joseph,michael friedmanMichael Friedman,berk gurpinarBerk Gurpinar,hsin-ching linHsin-Ching Lin,paul schalchPaul Schalch,ninos j josephNinos J Joseph,

    OBJECTIVES: We test the hypothesis that treatment of gastroesophageal reflux disease (GERD) can improve obstructive sleep apnea-hypopnea syndrome (OSAHS). METHODS: One hundred forty-six patients with OSAHS underwent a complete history-taking, physical examination, and laboratory testing, including questions related to GERD symptoms. Full-night attended polysomnography, 24-hour wireless pH study at the upper esophagus, snoring level evaluation, Epworth Sleepiness Scale, and quality-of-life surveys were completed for each patient. Patients who tested positive for GERD were treated with esomeprazole magnesium 40 mg once daily for 2 to 12 months. The 24-hour pH study was repeated, and those patients with elimination of GERD were reevaluated by polysomnography, snoring level evaluation, Epworth Sleepiness Scale, quality-of-life surveys, and subjective data collection. RESULTS: Forty-one patients completed single-dose treatment with esomeprazole, but the repeat 24-hour pH study showed that 9 patients had persistent GERD. In the 29 patients who completed phase 2 with normal pH study findings, the snoring level decreased from 9.7 +/- 0.5 to 7.9 +/- 1.3 (p < .0001), the Epworth Sleepiness Scale score decreased from 14.2 +/- 2.5 to 11.1 +/- 2.4 (p < .0001), the apnea-hypopnea index decreased from 37.9 +/- 19.1 to 28.8 +/- 11.5 (p = .006), and the minimum saturation of oxygen increased from 84.1% +/- 7.8% to 86.9% +/- 5.0% (p = .055). CONCLUSIONS: Treatment of GERD had a significant impact on the reduction of the apnea-hypopnea index, snoring, and daytime sleepiness. Elimination of GERD should be part of a comprehensive treatment plan for patients with OSAHS.

    Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Publishing Authors By Initials

    m friedmanM Friedman,b gurpinarB Gurpinar,hc linHC Lin,p schalchP Schalch,nj josephNJ Joseph,m friedmanM Friedman,b gurpinarB Gurpinar,hc linHC Lin,p schalchP Schalch,nj josephNJ Joseph,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Annals of otology, rhinology, and laryngology

    VOLUME: 116

    Page Numbers: 805-11

    Journal Abbreviation: Ann. Otol. Rhinol. Laryngol.

    ISSN: 0003-4894

    DAY: 13

    MONTH: Nov

    YEAR: 2007

    Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 407300

    Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome.

    AFFILIATION: Department of Otolaryngology and Bronchoesophagology, Rush University Medical Center, Chicago, IL, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ann Otol Rhinol Laryngol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News